...
首页> 外文期刊>Vaccine >Heat shock protein 70 fused to or complexed with Hantavirus nucleocapsid protein significantly enhances specific humoral and cellular immune responses in C57BL/6 mice.
【24h】

Heat shock protein 70 fused to or complexed with Hantavirus nucleocapsid protein significantly enhances specific humoral and cellular immune responses in C57BL/6 mice.

机译:与汉坦病毒核衣壳蛋白融合或复合的热激蛋白70可以显着增强C57BL / 6小鼠的特定体液和细胞免疫应答。

获取原文
获取原文并翻译 | 示例
           

摘要

Heat shock proteins (HSPs) are known to act as an effective molecular adjuvant to enhance the induction of antigen peptide-specific cellular immunity, when coupled with the antigen or peptide. Hantaan virus (HTNV) nucleocapsid protein (NP) is relatively conserved among hantaviruses and highly immunogenic in both animals and humans. To analyze the influence of HSP70 on NP vaccine potency, and evaluate the possibility of developing a novel effective vaccine against hantaviruses, we constructed prokaryotic expression plasmids, and expressed three recombinant proteins, namely, HTNV NP, HSP70 and HSP70-NP fusion protein. As an alternative to fusion protein, we also generated HSP70 and HTNV NP complexes (HSP70+NP) in vitro. C57BL/6 mice were immunized with those recombinant proteins, the humoral and cellular responses elicited against NP were measured by ELISA, fluorescence flow cytometry, cytotoxicity assays, and IFN-gamma ELISPOT assay. We found that immunization of mice with HSP70-NP fusion protein, or HSP70+NP complexes elicited significantly higher NP-specific antibody titers, frequencies of IFN-gamma-producing cells and cytotoxic T lymphocyte (CTL) activities in vivo than conventional HTNV NP vaccination. Antibody isotype analysis showed that the antibody response was characterized by a higher HTNV NP-specific titer of IgG2a than IgG1 antibodies, resulting in a significant higher IgG2a/IgG1 ratio. By comparison, HSP70-NP fusion protein is significantly superior to HSP70+NP complexes in enhancement of NP antigenicity. These results indicated that HSP70, when fused to or complexed with HTNV NP, greatly enhance NP vaccine potency by preferential induction of a predominant Th1 immune response in a NP-specific, HSP70-dependent manner.
机译:当与抗原或肽偶联时,已知热休克蛋白(HSP)可以作为有效的分子佐剂来增强对抗原肽特异性细胞免疫的诱导。汉坦病毒(HTNV)核衣壳蛋白(NP)在汉坦病毒中相对保守,在动物和人类中均具有高度免疫原性。为了分析HSP70对NP疫苗效力的影响,并评估开发针对汉坦病毒的新型有效疫苗的可能性,我们构建了原核表达质粒,并表达了三种重组蛋白,即HTNV NP,HSP70和HSP70-NP融合蛋白。作为融合蛋白的替代品,我们还在体外产生了HSP70和HTNV NP复合物(HSP70 + NP)。用这些重组蛋白免疫C57BL / 6小鼠,通过ELISA,荧光流式细胞术,细胞毒性测定和IFN-γELISPOT测定来测量针对NP引起的体液和细胞应答。我们发现,与传统的HTNV NP疫苗接种相比,用HSP70-NP融合蛋白或HSP70 + NP复合物对小鼠进行免疫接种会引起更高的NP特异性抗体滴度,体内产生IFN-γ的细胞的频率和细胞毒性T淋巴细胞(CTL)活性。 。抗体同种型分析表明,抗体应答的特征在于,与IgG1抗体相比,IgG2a的HTNV NP特异性滴度更高,从而导致IgG2a / IgG1比率明显升高。相比之下,HSP70-NP融合蛋白在增强NP抗原性方面明显优于HSP70 + NP复合物。这些结果表明,当与HTNV NP融合或复合时,HSP70通过以NP特异性,HSP70依赖性方式优先诱导主要的Th1免疫应答,大大增强了NP疫苗的效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号